SF3B1 and myelodysplastic syndrome: A possible scenario is that the early acquisition of SF3B1 mutations [13] and the presence of inflammation foster the emergence of HLA-DRlow/neg monocytes, which then contribute to counteract and balance inflammatory responses in established SF3B1mut MDS.